<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
		>
<channel>
	<title>Comments on: What Roche is shopping for – and why it’s shopping in Israel</title>
	<atom:link href="http://bostonbiotechwatch.com/2009/11/16/what-roche-is-shopping-for-%e2%80%93-and-why-it%e2%80%99s-shopping-in-israel/feed/" rel="self" type="application/rss+xml" />
	<link>http://bostonbiotechwatch.com/2009/11/16/what-roche-is-shopping-for-%e2%80%93-and-why-it%e2%80%99s-shopping-in-israel/</link>
	<description></description>
	<lastBuildDate>Mon, 26 Mar 2012 14:56:24 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
	<item>
		<title>By: Can the Amgen Takeout of Micromet Juice German Biotech? Can Anything? &#124; Boston Biotech Watch</title>
		<link>http://bostonbiotechwatch.com/2009/11/16/what-roche-is-shopping-for-%e2%80%93-and-why-it%e2%80%99s-shopping-in-israel/#comment-1425</link>
		<dc:creator><![CDATA[Can the Amgen Takeout of Micromet Juice German Biotech? Can Anything? &#124; Boston Biotech Watch]]></dc:creator>
		<pubDate>Tue, 13 Mar 2012 11:58:15 +0000</pubDate>
		<guid isPermaLink="false">http://bostonbiotechwatch.com/?p=48#comment-1425</guid>
		<description><![CDATA[[...] time I checked, the pharmaceutical industry was shutting down internal research and scouring the world for innovation. Some pharma CEOs are saying that pharma should not invest in internal R&amp;D at all any more. By [...]]]></description>
		<content:encoded><![CDATA[<p>[...] time I checked, the pharmaceutical industry was shutting down internal research and scouring the world for innovation. Some pharma CEOs are saying that pharma should not invest in internal R&amp;D at all any more. By [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

